What type of study is this?

This is a Systematic Review study.

September 24, 2025Cancer Biology and MedicineOpen Access

Research progress and challenges in the treatment of oncogene-addicted non-small cell lung cancer

View Full Paper

Ask AI

Bookmark

Authors

HLHong LiBGI Group (China)XLXuanguang LiTianjin Medical University General Hospital TLTong LiDalian Medical University

Discussion

Member takes

Implication

Review highlights progress in targeted therapy and novel treatments for non-small cell lung cancer, suggesting ongoing improvements in patient outcomes.

Key Points

Substantial advances have improved patient outcomes in non-small cell lung cancer through targeted therapies.
Tyrosine kinase inhibitors targeting EGFR, ALK, and other oncogenes show significant antitumor activity.
Novel therapies such as immunotherapy and antibody-drug conjugate therapy have also increased treatment options.
Systematic reviews and findings from recent conferences emphasize the importance of ongoing research in treatment strategies.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68d6d8548b2b6861e4c3e589 https://doi.org/10.20892/j.issn.2095-3941.2025.0153

View Full Paper

Ask AI

Bookmark

Implication

Review highlights progress in targeted therapy and novel treatments for non-small cell lung cancer, suggesting ongoing improvements in patient outcomes.

Research progress and challenges in the treatment of oncogene-addicted non-small cell lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Research progress and challenges in the treatment of oncogene-addicted non-small cell lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider